| Cat. No. |
Product Name & Pharmacological Action |
| 0204 | D-Alanine |
| Weak glycine receptor agonist |
| 0205 | L-Alanine |
| Glycine receptor agonist, more potent than D-isomer (0204) |
| 0206 | β-Alanine |
| Endogenous glycine agonist, more selective than Taurine (Cat. No. 0209) |
| 0208 | Hypotaurine |
| Non-selective endogenous glycine receptor agonist |
| 0209 | Taurine |
| Non-selective, endogenous glycine receptor partial agonist |
| 0213 | D-Aspartic acid |
| NMDA agonist |
| 0214 | L-Aspartic acid |
| NMDA agonist |
| 0216 | L-Cysteinesulfinic acid |
| NMDA and mGlu agonist |
| 0217 | D-Glutamic acid |
| NMDA agonist, less active enantiomer |
| 0218 | L-Glutamic acid |
| Endogenous NMDA agonist |
| 0219 | Glycine |
| Endogenous potentiator, co-transmitter |
| 0222 | Kainic acid |
| Potent excitant and neurotoxin |
| 0223 | Kynurenic acid |
| Broad spectrum EAA antagonist |
| 0225 | Quinolinic acid |
| Transmitter candidate |
| 0226 | D-Serine |
| Potentiator, acts glycine site |
| 0227 | L-Serine |
| Weak endogenous glycine receptor agonist |
| 0234 | Guvacine hydrochloride |
| Specific GABA uptake inhibitor |
| 0235 | Isoguvacine hydrochloride |
| Selective GABAA agonist |
| 0236 | (±)-Nipecotic acid |
| GABA uptake inhibitor |
| 0237 | 7-Chlorokynurenic acid |
| Potent, competitive inhibitor of L-glutamate uptake |
| 0238 | O-Phospho-L-serine |
| Group III mGlu agonist |
| 0245 | 2-Hydroxysaclofen |
| Selective GABAB antagonist, more potent than saclofen (Cat. No. 0246) |
| 0246 | Saclofen |
| Selective GABAB antagonist |
| 0247 | (R)-CPP |
| More active enantiomer |
| 0253 | (R)-AMPA |
| Inactive isomer of (RS)-AMPA (0169) |
| 0254 | (S)-AMPA |
| Selective AMPA agonist. Active isomer |
| 0258 | ACBC |
| NMDA antagonist, acts glycine site |
| 0262 | 2,4-Dihydroxyphenylacetyl-L-asparagine |
| Component of Joro spider toxin |
| 0269 | Domoic acid |
| Potent, selective kainate agonist |
| 0270 | trans-ACBD |
| Selective, very potent NMDA agonist |
| 0271 | cis-ACBD |
| Potent, selective L-glutamate uptake inhibitor |
| 0281 | (R)-(+)-HA-966 |
| Partial NMDA agonist, acts glycine site |
| 0282 | (S)-(-)-HA-966 |
| NMDA antagonist/partial agonist |
| 0284 | (1S,3R)-ACPD |
| Group I/group II mGlu agonist |
| 0285 | Ibotenic acid |
| Non-selective NMDA agonist |
| 0286 | 5,7-Dichlorokynurenic acid |
| Potent NMDA antagonist, acts glycine site |
| 0289 | Muscimol |
| Potent GABAA agonist |
| 0290 | N-(4-Hydroxyphenylacetyl)spermine |
| Wasp toxin analogue |
| 0291 | N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride |
| Non-selective EAA antagonist |
| 0298 | L-trans-2,4-PDC |
| Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor |
| |
